The Januvia Lawsuit Center provides comprehensive, up-to-date information about the dangers of the medication and the legal options of those harmed by it.

Januvia Lawsuit Center

Research shows the antidiabetic drug sitagliptin phosphate—sold under the brand name Januvia (and as Janumet when combined with metformin)—causes acute pancreatitis and pancreatic cancer.

 

In March 2013, the FDA announced that it is evaluating findings that connects Januvia with pancreatitis and cellular changes called “pancreatic duct metaplasia.”

Start your free case evaluation

or call Toll Free: 1-888-976-8529

If you’ve suffered harm resulting from taking Januvia, then you might have a case against Merck & Co., the manufacturer of the drug.

 

You’ll need to make a claim, though, and your time to do so is limited. Call us now and speak to one of our lawyers, at no cost or risk. We can determine promptly whether you have grounds for a lawsuit.

Start your free case evaluation

or call Toll Free: 1-888-976-8529

If you were prescribed Januvia, then developed cancer, you might be entitled to compensation for your injuries, including out-of-pocket costs, lost wages, and pain and suffering.

 

 

Don’t expect the drug’s maker to volunteer to write you a check, though. You’ll need to demand to be made whole.

Start your free case evaluation

or call Toll Free: 1-888-976-8529

Latest Updates

FDA Investigating Januvia’s Link to Increased Risk of Pancreatic Cancer

While Januvia’s label bears a warning about the drug’s tendency to increase a patient’s risk of pancreatitis, a painful inflammation of the pancreas, Januvia’s link to pancreatic cancer, which kills most of its victims within a year, is less settled. But a recent study by the chairman of endocrinology at the University of California, Los Angeles, may change that…. Read more